248 related articles for article (PubMed ID: 34063776)
1. An Integrated Transcriptomic Approach to Identify Molecular Markers of Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.
Rhone ET; Bardhi E; Bontha SV; Walker PD; Almenara JA; Dumur CI; Cathro H; Maluf D; Mas V
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063776
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction.
Maluf DG; Dumur CI; Suh JL; Lee JK; Cathro EP; King AL; Gallon L; Brayman KL; Mas VR
Am J Transplant; 2014 May; 14(5):1152-1163. PubMed ID: 24698514
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients.
Kuypers DR; Naesens M; de Jonge H; Lerut E; Verbeke K; Vanrenterghem Y
Ther Drug Monit; 2010 Aug; 32(4):394-404. PubMed ID: 20526235
[TBL] [Abstract][Full Text] [Related]
4. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
Höcker B; Tönshoff B
Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
[TBL] [Abstract][Full Text] [Related]
6. Proteomic Characterization of Urinary Extracellular Vesicles from Kidney-Transplanted Patients Treated with Calcineurin Inhibitors.
Carreras-Planella L; Juega J; Taco O; Cañas L; Franquesa M; Lauzurica R; Borràs FE
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066346
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional profiling of belatacept and calcineurin inhibitor therapy in renal allograft recipients.
Vitalone MJ; Ganguly B; Hsieh S; Latek R; Kulbokas EJ; Townsend R; Sarwal MM
Am J Transplant; 2014 Aug; 14(8):1912-21. PubMed ID: 24954576
[TBL] [Abstract][Full Text] [Related]
8. A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies.
Kambham N; Nagarajan S; Shah S; Li L; Salvatierra O; Sarwal MM
Clin J Am Soc Nephrol; 2007 Jan; 2(1):135-42. PubMed ID: 17699397
[TBL] [Abstract][Full Text] [Related]
9. Utilization of an EMR-biorepository to identify the genetic predictors of calcineurin-inhibitor toxicity in heart transplant recipients.
Oetjens M; Bush WS; Birdwell KA; Dilks HH; Bowton EA; Denny JC; Wilke RA; Roden DM; Crawford DC
Pac Symp Biocomput; 2014; ():253-64. PubMed ID: 24297552
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Results in Recipients of Late Conversion to a Calcineurin Inhibitor-Free Regimen with Everolimus After Kidney Transplantation.
Iwahara N; Hotta K; Hirose T; Shinohara N
Transplant Proc; 2023 May; 55(4):803-808. PubMed ID: 37147197
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in kidney transplant biopsies.
Kumar A; Hammad A; Sharma AK; Mc-Cardle F; Rustom R; Christmas SE
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():207-13. PubMed ID: 25894156
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive analyses of kidney injury molecule-1 messenger RNA in kidney transplant recipients with graft dysfunction.
Nogare AL; Dalpiaz T; Veronese FJ; Gonçalves LF; Manfro RC
Transplant Proc; 2012 Oct; 44(8):2297-9. PubMed ID: 23026578
[TBL] [Abstract][Full Text] [Related]
13. Genomic-derived markers for early detection of calcineurin inhibitor immunosuppressant-mediated nephrotoxicity.
Cui Y; Huang Q; Auman JT; Knight B; Jin X; Blanchard KT; Chou J; Jayadev S; Paules RS
Toxicol Sci; 2011 Nov; 124(1):23-34. PubMed ID: 21865292
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity.
Gooch JL; King C; Francis CE; Garcia PS; Bai Y
PLoS One; 2017; 12(4):e0175242. PubMed ID: 28414804
[TBL] [Abstract][Full Text] [Related]
15. Computational Prediction of Biomarkers, Pathways, and New Target Drugs in the Pathogenesis of Immune-Based Diseases Regarding Kidney Transplantation Rejection.
Alfaro R; Martínez-Banaclocha H; Llorente S; Jimenez-Coll V; Galián JA; Botella C; Moya-Quiles MR; Parrado A; Muro-Perez M; Minguela A; Legaz I; Muro M
Front Immunol; 2021; 12():800968. PubMed ID: 34975915
[TBL] [Abstract][Full Text] [Related]
16. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
[TBL] [Abstract][Full Text] [Related]
18. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
Wali RK; Weir MR
Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
[TBL] [Abstract][Full Text] [Related]
19. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
Yagisawa T; Omoto K; Shimizu T; Ishida H; Tanabe K
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
[TBL] [Abstract][Full Text] [Related]
20. A comparative study on renal biopsy before and after long-term calcineurin inhibitors therapy: an insight for pathogenesis of its toxicity.
Singh L; Singh G; Sharma A; Sinha A; Bagga A; Dinda AK
Hum Pathol; 2015 Jan; 46(1):34-9. PubMed ID: 25449629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
